Benzodiazepine receptor binding in Huntington's disease: [11C]Flumazenil uptake measured using positron emission tomography

2000 ◽  
Vol 47 (5) ◽  
pp. 644-648 ◽  
Author(s):  
Gabriella K�nig ◽  
Klaus L. Leenders ◽  
Rosario Sanchez-Pernaute ◽  
Angelo Antonini ◽  
Peter Vontobel ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Receptor Binding ◽  
Benzodiazepine Receptor ◽  
Emission Tomography ◽  
Positron Emission

Positron emission tomography after fetal transplantation in Huntington's disease

2005 ◽  
Vol 58 (2) ◽  
pp. 331-337 ◽  
Author(s):  
Sarah Furtado ◽  
Vesna Sossi ◽  
Roberta A. Hauser ◽  
Ali Samii ◽  
Michael Schulzer ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Emission Tomography ◽  
Positron Emission

Positron emission tomography in the early diagnosis of Huntington's disease

Neurology ◽  
1986 ◽  
Vol 36 (7) ◽  
pp. 888-888 ◽  
Author(s):  
M. R. Hayden ◽  
W.R.W. Martin ◽  
A. J. Stoessl ◽  
C. Clark ◽  
S. Hollenberg ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Early Diagnosis ◽  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Emission Tomography ◽  
Positron Emission

The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease

Neurology ◽  
1987 ◽  
Vol 37 (9) ◽  
pp. 1441-1441 ◽  
Author(s):  
M. R. Hayden ◽  
J. Hewitt ◽  
A. J. Stoessl ◽  
C. Clark ◽  
W. Ammann ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Huntington's Disease ◽  
Huntington’S Disease ◽  
Emission Tomography ◽  
Dna Polymorphisms ◽  
Positron Emission ◽  
Combined Use
Sign in / Sign up

Export Citation Format

Share Document